Vaxart Inc. (VXRT)
OTC
Closed
Oct 23, 2026
Day's Range
0.410052 wk Range
0.3100Overview - VXRT - Vaxart Inc.
Key Statistics
Valuation
Enterprise Value
58.49M
P/E (Trailing)
2.64
P/E (Forward)
-0.43
PEG Ratio
-0.18
Price / Sales (TTM)
0.45
Price / Book
1.32
EV / EBITDA
1.28
Profitability
Profit Margin
15.87%
Operating Margin
-48.45%
Return on Assets
15.03%
Return on Equity
66.96%
Ownership
Shares Outstanding
242.83M
Float
239.24M
Short % of Shares Outstanding
7.51%
Held by Insiders
1.42%
Held by Institutions
0.05%
Price stats
Beta
1.05
50-Day Avg
0.4854
200-Day Avg
0.5906
Dividends
Payout Ratio
0.00%
Analyst Consensus
3 analysts
Average price target
$ 3.33Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - VXRT - Vaxart Inc.
Peers - VXRT - Vaxart Inc.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
Profile Summary - VXRT - Vaxart Inc.
About
Vaxart Inc. is a biotechnology company specializing in the development of oral recombinant vaccines. Its primary function is to create vaccine candidates that can be administered in tablet form, offering a painless and potentially more accessible alternative to traditional injectable vaccines. This innovation is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
